60 Degrees Pharmaceuticals, Inc. Common Stock

SXTP XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

3.9M

Short interest (Jul 15)

5.5%

Net Short (Jul 27 ): 0.0%

Borrow Fee

27.94%

↓ 2.0%

Available Shares

400K

↑ 24.6%

Price Chart

Company Overview

60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. Currently, company's pipeline under development covers development programs for vector-borne, fungal, and viral diseases utilizing three of the Company's future products: (i) new products that contain the Arakoda regimen of Tafenoquine; (ii) new products that contain Tafenoquine; and (iii) Celgosivir and/or botanical extracts from Australian Chestnut Trees.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001946563

Asset Type: CS

Market Data

Market Cap: $3,935,746

Employees: 3

Status: Active

Short Interest

Current Borrow Fee 27.94%

Range: 27.94% - 27.98%

Available Shares 400K

Range: 250K - 350K

Recent Changes

Fee Change: ↓ 0.7%

Available Change: ↑ 133.3%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime